FFC#26/2019

Standardized Ventilation Inflammation Perfusion and Structure (VIPS) MRI platform for monitoring Cystic Fibrosis Lung Disease

AREA 5 Clinical and Epidemiological research

FFC#26/2019

Standardized Ventilation Inflammation Perfusion and Structure (VIPS) MRI platform for monitoring Cystic Fibrosis Lung Disease
€ 0 still needed
0%
€ 75.000 goal

pRINCIPAL INVESTIGATOR

Giovanni Morana (Ospedale Ca’ Foncello, Dip. Radiologia Diagnostica e Interventistica, Treviso)

Researchers

5

Category

AREA 5 Clinical and Epidemiological research

Duration

2 years

Goal

€ 75.000

Funds raised

€ 75.000

Objectives

Fourier Decomposition is a novel Magnetic Resonance Imaging (FD-MRI) method that allows obtaining perfusion and ventilation images without intravenous and gaseous contrast agents. FD-MRI could provide new outcomes measures for the monitoring of Cystic Fibrosis Lung Disease. Before introducing FD-MRI in CF clinical practice, researchers need to validate this technique against standard as Computed Tomography (CT) and perfusion MRI techniques. The final goal of this validation plan is to develop an MRI protocol that provide information about ventilation, inflammation, perfusion and structure (VIPS-MRI) in a single examination of 30 minutes. To validate the new technique 80 patients with CF scheduled for their periodical CT will be asked to participate. Participation will entail an MRI study, performed the same day of the CT or within a week. Primary parameters obtained by the different techniques and measuring ventilation and perfusion will be assessed and compared using appropriate statistic tests. The new VIPS-MRI protocol may improve detection and quantification of structural and functional changes in the CF patients.

WHO ADOPTED THE PROJECT

Delegazione FFC di Vittoria Ragusa e Siracusa con Delegazione FFC di Catania Mascalucia

€ 75.000

Delegazione FFC di Cerea “Il sorriso di Jenny”

€ 12.000

Matilde e Paola per Elsa

€ 10.000

OTHER PROJECTS

Discover the other projects

GMRF#1/2026

Exploring the role of PKD1 in promoting CFTR stability and function at the cell surface

FFC#1/2026

Mapping proteins regulating CFTR mRNA stability to identify new therapeutic targets for nonsense mutations

FFC#2/2026

Evaluating the potential of phosphodiesterase inhibitors to enhance the efficacy of CFTR modulators and support personalized therapeutic approaches